Company Background

Type of Company

Alveolus provides medical stent technology in the emerging field of non-vascular interventional stenting. The company, whose products are developed by physicians for physicians, is designing, manufacturing and testing a Stent Technology System (STS) and other advanced devices for the battle against cancerous and benign obstructive lumen disease.

Products

Alveolus has developed next-generation stent technology for use in the lungs, esophagus, and biliary tract. The company also has an endoscopic guidewire available for use in both interventional pulmonary and endoscopic procedures along with a tracheobronchial stent sizing device to minimize stent mis-sizing with accurate lumenal measurements in pulmonary procedures.

Year Founded

2001

Headquarters

Charlotte, NC, USA